Calcineurin (Ppp3Ca) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Calcineurin (Ppp3Ca) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Calcineurin is a calcium/calmodulin-dependent serine/threonine protein phosphatase that plays a critical role in cellular signal transduction, particularly in [neurons](/entities/neurons) where it regulates synaptic plasticity, gene transcription, and neuronal survival. It is one of the few known serine/threonine phosphatases that requires calcium/calmodulin for activation, making it a key mediator of calcium-dependent signaling pathways in the nervous system[@klee1979][@rusnak2000].
Structure
Calcalcineurin is a heterodimer composed of:
Calcineurin A (catalytic subunit): A 60 kDa protein with a catalytic domain, a regulatory domain containing the calmodulin-binding region, and an autoinhibitory domain[@klee1979]
Calcineurin B (regulatory subunit): A 19 kDa calcium-binding protein that confers calcium sensitivity to the complex[@stemmer1994]
The enzyme contains:
A catalytic domain (~300 residues) with the characteristic metal-binding active site
A calmodulin-binding domain that undergoes conformational changes upon calcium/calmodulin binding
An autoinhibitory domain that blocks the active site in the absence of calcium
Normal Function in the Nervous System
Synaptic Plasticity
Calcineurin plays a central role in regulating synaptic plasticity, a cellular basis for learning and memory:
Long-term depression (LTD): Calcineurin dephosphorylates AMPA receptor subunits, leading to receptor internalization and LTD induction[@beattie2000]
[Long-term potentiation](/mechanisms/long-term-potentiation) (LTP): Through dephosphorylation of various substrates, calcineurin modulates [LTP](/mechanisms/long-term-potentiation) consolidation
Synaptic vesicle cycling: Regulates vesicle release probability and recycling
Calcineurin is hyperactivated in Alzheimer's disease and contributes to pathogenesis:
Amyloid-beta (Aβ) toxicity: Aβ induces calcium dysregulation that overactivates calcineurin, leading to pathological dephosphorylation events[@huang2015]
Systemic immunosuppression from calcineurin inhibition
Narrow therapeutic window
Need for neuron-specific targeting
Key Publications
Klee CB, Crouch TH, Krinks MH. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A. 1979;76(12):6270-6273. [DOI:10.1073/pnas.76.12.6270](https://doi.org/10.1073/pnas.76.12.6270)
Wang HG, Pathan N, Ethell IM, et al. Ca2+-induced [apoptosis](/entities/apoptosis) through calcineurin dephosphorylation of BAD. Science. 1999;284(5412):339-343. [DOI:10.1126/science.284.5412.339](https://doi.org/10.1126/science.284.5412.339)
Bhat RV, Shaner J, Beyreuther K, et al. The role of calcineurin in [amyloid-beta](/proteins/amyloid-beta) peptide-induced neurodegeneration. J Neural Transm Suppl. 2000;(58):197-209. [DOI:10.1007/978-3-7091-6284-2_16](https://doi.org/10.1007/978-3-7091-6284-2_16)
Beattie EC, Carroll RC, Yu X, et al. Regulation of AMPA receptor endocytosis by a memory mechanism involving calcineurin. Nat Neurosci. 2000;3(4):387-392. [DOI:10.1038/73947](https://doi.org/10.1038/73947)
Sato K, Saito H, Matsuki N. Calcineurin as a金融服务 in neuronal dysfunction. Mol Neurobiol. 2006;33(2):143-156. [DOI:10.1385/MN:33:2:143](https://doi.org/10.1385/MN:33:2:143)
Norris CM, Blalock EM, Chen KC, et al. Calcineurin triggers Ca2+/calmodulin-dependent protein phosphatase cascade in hippocampal aging. J Neurosci. 2002;22(4):1731-1741. [DOI:10.1523/JNEUROSCI.22-04-01731.2002](https://doi.org/10.1523/JNEUROSCI.22-04-01731.2002)
Reese LC, Taglialatela G. A role for calcineurin in Alzheimer's disease. Curr Neuropharmacol. 2011;9(4):685-692. [DOI:10.2174/157015911798376262](https://doi.org/10.2174/157015911798376262)
Lynch DR, McDonald PS, Sanyal A, et al. Calcineurin in motor neuron biology and disease. Mol Neurobiol. 2005;31(1-3):85-98. [DOI:10.1385/MN:31:1-3:085](https://doi.org/10.1385/MN:31:1-3:085)
The study of Calcineurin (Ppp3Ca) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
[Allen Human Brain Atlas*:](/datasets/allen-human-brain-atlas) [CALCINEURIN (PPP3CA) expression](https://human.brain-map.org/microarray/search/show?search_term=CALCINEURIN (PPP3CA))
Allen Cell Type Atlas: [CALCINEURIN (PPP3CA) cell type expression](https://celltypes.brain-map.org/)
[Klee CB, Crouch TH, Krinks MH, Calcineurin: a calcium- and calmodulin-binding protein of the nervous system (1979)](https://pubmed.ncbi.nlm.nih.gov/293146/)
[Rusnak F, Mertz P, Calcineurin: form and function (2000)](https://doi.org/10.1152/physrev.2000.80.4.1483)
[Stemmer PM, Klee CB, Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B (1994)](https://doi.org/10.1021/bi00188a015)
[Beattie EC, Carroll RC, Yu X, et al, Regulation of AMPA receptor endocytosis by a memory mechanism involving calcineurin (2000)](https://doi.org/10.1038/73947)
[Crabtree GR, Olson EN, NFAT signaling: choreographing the social lives of cells (2002)](https://doi.org/10.1016/S0092-8674(02)
[Huang W, Lv D, Yu H, et al, Calcineurin-mediated amyloid-beta pathology in Alzheimer's disease (2015)](https://doi.org/10.3233/JAD-150217)
[Reese LC, Taglialatela G, A role for calcineurin in Alzheimer's disease (2011)](https://doi.org/10.2174/157015911798376262)
[Frugier T, Taylor JM, McLean C, et al, Calcineurin expression in activated glial cells in ALS (2005)](https://doi.org/10.1016/j.molbrainres.2005.05.017)
[Liu J, Farmer JD Jr, Lane WS, et al, Calcineurin is a common target of cyclophilin A and FKBP12 (1991)](https://doi.org/10.1016/0092-8674(91)
[Steiner JP, Dawson TM, Fotuhi M, et al, Neuroprotective effects of inhibitors of calcineurin (1994)](https://doi.org/10.1002/ana.410360312)
[Dell'Acqua ML, Smith KE, Gerges NZ, et al, Dynamic regulation of the scaffolding protein AKAP79/150 by calcineurin (2006)](https://doi.org/10.1101/sqb.2006.71.060)
[Shin HG, Lee J, Kim HR, et al, Inhibition of calcineurin attenuates excitotoxicity and prevents mitochondrial dysfunction in hippocampal neurons (2017)](https://doi.org/10.1016/j.neuropharm.2017.01.039)
Pathway Diagram
The following diagram shows the key molecular relationships involving Calcineurin (PPP3CA) discovered through SciDEX knowledge graph analysis: